Faes Farma, S.A. (FAE.MC)
EUR 4.31
(0.94%)
EUR 4.31
(0.94%)
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2023 | 4.37 Million EUR | -0.61% |
| 2022 | 4.4 Million EUR | 103.61% |
| 2021 | 2.16 Million EUR | 31.37% |
| 2020 | 1.64 Million EUR | -48.27% |
| 2019 | 3.18 Million EUR | 259.32% |
| 2018 | 885 Thousand EUR | -97.94% |
| 2017 | 43.05 Million EUR | 1435000.0% |
| 2016 | 3000.00 EUR | -76.92% |
| 2015 | 13 Thousand EUR | -99.76% |
| 2014 | 5.32 Million EUR | -74.07% |
| 2013 | 20.53 Million EUR | -39.44% |
| 2012 | 33.89 Million EUR | 7.78% |
| 2011 | 31.45 Million EUR | -2.09% |
| 2010 | 32.12 Million EUR | -27.65% |
| 2009 | 44.4 Million EUR | 78.72% |
| 2008 | 24.84 Million EUR | 0.0% |
| 2007 | - EUR | -100.0% |
| 2006 | 41.7 Million EUR | 0.0% |
| 2005 | - EUR | 0.0% |
| 2004 | - EUR | 0.0% |
| 2003 | - EUR | 0.0% |
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2024 Q1 | - EUR | -100.0% |
| 2024 Q2 | 3.63 Million EUR | 0.0% |
| 2023 FY | 4.37 Million EUR | -0.61% |
| 2023 Q2 | 5.03 Million EUR | 0.0% |
| 2023 Q1 | - EUR | -100.0% |
| 2023 Q3 | - EUR | -100.0% |
| 2023 Q4 | 7.83 Million EUR | 0.0% |
| 2022 FY | 4.4 Million EUR | 103.61% |
| 2022 Q2 | 1.91 Million EUR | 0.0% |
| 2022 Q4 | 4.4 Million EUR | 0.0% |
| 2022 Q1 | - EUR | -100.0% |
| 2022 Q3 | - EUR | -100.0% |
| 2021 Q3 | - EUR | -100.0% |
| 2021 FY | 2.16 Million EUR | 31.37% |
| 2021 Q4 | 2.16 Million EUR | 0.0% |
| 2021 Q1 | - EUR | -100.0% |
| 2021 Q2 | 3.06 Million EUR | 0.0% |
| 2020 FY | 1.64 Million EUR | -48.27% |
| 2020 Q4 | 1.64 Million EUR | 0.0% |
| 2020 Q1 | - EUR | -100.0% |
| 2020 Q2 | 3 Million EUR | 0.0% |
| 2019 FY | 3.18 Million EUR | 259.32% |
| 2019 Q1 | - EUR | -100.0% |
| 2019 Q2 | 231 Thousand EUR | 0.0% |
| 2019 Q3 | 6.37 Million EUR | 2657.58% |
| 2019 Q4 | 3.18 Million EUR | -50.08% |
| 2018 Q2 | 1.43 Million EUR | 0.0% |
| 2018 Q1 | - EUR | -100.0% |
| 2018 FY | 885 Thousand EUR | -97.94% |
| 2018 Q4 | 885 Thousand EUR | 0.0% |
| 2018 Q3 | - EUR | -100.0% |
| 2017 FY | 43.05 Million EUR | 1435000.0% |
| 2017 Q3 | - EUR | -100.0% |
| 2017 Q4 | 43.05 Million EUR | 0.0% |
| 2017 Q2 | 48.81 Million EUR | 0.0% |
| 2017 Q1 | - EUR | -100.0% |
| 2016 Q1 | - EUR | -100.0% |
| 2016 Q2 | - EUR | 0.0% |
| 2016 Q3 | - EUR | 0.0% |
| 2016 Q4 | 3000.00 EUR | 0.0% |
| 2016 FY | 3000.00 EUR | -76.92% |
| 2015 Q3 | - EUR | -100.0% |
| 2015 FY | 13 Thousand EUR | -99.76% |
| 2015 Q4 | 13 Thousand EUR | 0.0% |
| 2015 Q2 | 2.04 Million EUR | 0.0% |
| 2015 Q1 | - EUR | -100.0% |
| 2014 Q4 | 5.32 Million EUR | 0.0% |
| 2014 FY | 5.32 Million EUR | -74.07% |
| 2014 Q1 | - EUR | -100.0% |
| 2014 Q2 | 23.94 Million EUR | 0.0% |
| 2014 Q3 | - EUR | -100.0% |
| 2013 FY | 20.53 Million EUR | -39.44% |
| 2013 Q2 | 28.67 Million EUR | 0.0% |
| 2013 Q4 | 20.53 Million EUR | 0.0% |
| 2013 Q3 | - EUR | -100.0% |
| 2013 Q1 | - EUR | -100.0% |
| 2012 Q3 | - EUR | -100.0% |
| 2012 Q2 | 42.45 Million EUR | 0.0% |
| 2012 FY | 33.89 Million EUR | 7.78% |
| 2012 Q4 | 33.89 Million EUR | 0.0% |
| 2011 FY | 31.45 Million EUR | -2.09% |
| 2011 Q2 | 32.65 Million EUR | 0.0% |
| 2011 Q4 | 31.45 Million EUR | 0.0% |
| 2010 FY | 32.12 Million EUR | -27.65% |
| 2009 FY | 44.4 Million EUR | 78.72% |
| 2008 FY | 24.84 Million EUR | 0.0% |
| 2007 FY | - EUR | -100.0% |
| 2006 FY | 41.7 Million EUR | 0.0% |
| 2005 FY | - EUR | 0.0% |
| 2004 FY | - EUR | 0.0% |
| 2003 FY | - EUR | 0.0% |
| Name | Long Term Debt | Long Term Debt Difference |
|---|---|---|
| Almirall, S.A. | 386.03 Million EUR | 98.867% |
| Laboratorio Reig Jofre, S.A. | 19.83 Million EUR | 77.955% |